Gene-targeted mice deficient in the DNA repair enzyme Ung uracil-DNA glycosylase are viable but exhibit a detectable low steady-state level of uracil partly replacing thymine in their genome. Furthermore, spleen cells from such animals have a slightly increased mutation frequency, apparently due to deaminated DNA cytosine residues (Nilsen et al., 2000) . These Ung À/À mice show a perturbed somatic hypermutation pattern in expressed antibody V genes, consistent with reduced excision of uracil from DNA, and class switch recombination is also substantially inhibited (Rada et al., 2002) . Similar observations have been made for Ung-deficient human individuals, who show altered somatic hypermutation of V genes and impaired isotype switching with accumulation of IgM to high levels (Imai et al., 2003) .
Somatic hypermutation has been detected not only in antibody V genes but aberrantly also in a small number of other genes in human B-cell lymphomas, including bcl-6 and c-myc, although not generally in tumor suppressor genes such as p53 (Pasqualucci et al., 2001 ). The Aid enzyme, which serves an obligatory role in somatic hypermutation and class switch recombination Revy et al., 2000) , is expressed at high levels in lymphomas derived from germinal center B-cells, but not in other B-cell lymphomas (Pasqualucci et al., 2004) .
Aging Ung-deficient mice develop B-cell lymphomas (Nilsen et al., 2003) . In an attempt to clarify the emergence of B-cell tumors in Ung À/À mice, we have investigated the Aid levels and bcl-6, c-myc, and p53 mutation patterns in tumors from such mice.
Spleens and lymph nodes heavily infiltrated with tumor cells from three aging (15-25-month old) Ung Cultures (3-day) of spleen and lymph node cells (eBioscience protocol) from Ung þ / þ control mice, Ung À/À mice, and a rapidly proliferating lymph node tumor from an Ung-negative mouse called 8-Ung À/À , were used. Aid production was induced by inclusion of 10 mg/ml lipopolysaccharide (LPS, Sigma) and 10 ng/ ml interleukin 4 (IL-4, Sigma) in the growth medium. B-cells expressing the CD19 cell-surface marker were enriched by magnetic cell separation (as recommended by the manufacturer, Miltenyi Biotech, Germany). Aid mRNA expression was then determined in stimulated (black bars) and unstimulated (open bars) cells by realtime PCR using an ABI Prism 7900HT detection system and a standard TacMan protocol (Applied Biosystems). Aid cDNA was subsequently amplified for DNA sequencing were employed (Nilsen et al., 2003) . Spleens and lymph nodes from three normal Ung þ / þ mice were also investigated as controls. In addition, an unusually large (over 50 times normal node size) mesenteric lymph node tumor from a fourth Ung À/À mouse (code name 8-Ung À/À ) was analysed separately. Cultures (3-day) of cell suspensions of all the tumor material were used, and CD19-positive B-cells were purified by magnetic cell separation. For analysis of Aid expression, real-time PCR of mRNA from the short-term cultures was performed. As a positive control for Aid expression, aliquots of each short-term culture were stimulated for 3 days in the presence of LPS and IL-4. Aid transcripts were not detected in the tumors from three Ung À/À mice in the absence of mitogenic stimulation (Figure 1 ). In contrast, the single very large 8-Ung À/À tumor had a high level of Aid mRNA even in the absence of mitogenic stimulation ( Figure 1 ). Thus, the B-cell lymphomas occurring in Ung À/À mice did not generally overproduce Aid, but one rapidly proliferating tumor showed constitutive expression at the level achieved in the other material, including tumor-free controls, only after stimulation with LPS and IL-4 (Figure 1) .
Sequencing of 32 individual clones of Aid cDNA from 8-Ung À/À revealed coding region mis-sense mutations in 22 clones. There was a weak bias for mutations at G/C basepairs (57%), of which 95% were transition mutations, with 10% at RGYW/WRCY motifs. Mutations clustered in the APOBEC-like C-terminal domain, but amino-acid changes were also found in the N-terminal helix region and in the linker region. Only one mutation was found in the extreme N-terminal part of the dCMP/ cytidine deaminase active site domain. No mutations causing premature termination were detected. However, mutations were also found in the promoter region in 80% (12/15) of the clones. No mutation was identified in 20 individual clones of Aid cDNA or the promoter region from wild-type mice, and only one mis-sense mutation was identified among 22 clones from the three Ung À/À samples. The data indicate that in the single case of deregulated Aid expression, Aid itself accumulated mutations throughout the gene. This is in agreement with the hypermutation of an AID transgene observed previously in cells overexpressing AID (Martin and Scharff, 2002) . It is interesting that in the present case overexpression of Aid in an Ung-negative background resulted in the emergence of a lymphoma of CD19-positive B-cells, whereas T-cell tumors arise in Ungpositive transgenic mice overexpressing Aid (Okazaki et al., 2003) .
Spectral karyotyping of several Ung À/À lymphomas from spleens did not reveal any distinct translocations (data not shown). We estimate that typical large IgH/cmyc translocations of the type described by Coleman et al. (2000) in mice would have been detected. In order to determine single-site mutation frequencies in purified B-cells from lymphomas and controls, nontranslated regions of the p53, bcl-6, and c-myc genes ( Figure 2a (Figure 2b ). This is in good agreement with the previously noted modest 1.3-1.4-fold increase in mutation frequency in a nontranscribed reporter gene in Ung À/À mice (Nilsen et al., 2000) . The unusual 8-Ung
tumor showed a sixfold and threefold increased mutation frequencies at the bcl-6 and c-myc loc, respectively (Figure 2b ). The data are consistent with the accumulation of mutations in the Aid locus of the 8-Ung
tumor. The results did not reflect a general mutator effect in 8-Ung À/À , however, because a similar increase in mutation frequency did not occur in the p53 gene (Figure 2b) . Instead, the data suggest marked aberrant somatic hypermutation in 8-Ung À/À in certain target genes associated with B-cell lymphoma (Pasqualucci et al., 2001) .
Further mutation analysis at the bcl-6 and p53 loci showed higher numbers of clones with two to four mutations per clone, and lower numbers with no mutations, for Ung À/À tumors compared to controls (Figure 3a and b) . These results confirm the modest increase in mutation frequency of the Ung À/À material shown in Figure 2b . With regard to the large 8-Ung À/À lymphoma, this had multiple mutations with several isolates showing >10 mutations per clone for bcl-6 but not for p53 ( Figure(3a and b, respectively) , again in confirmation of the initial results on mutation frequencies (Figure 2b) . A more detailed analysis of the mutations in bcl-6 is shown in Table 1 . Mutations at RGYW/WRCY sequences, which are frequently targeted by somatic hypermutation (Rogozin and Kolchanov, 1992) , were not significantly different between typical Ung À/À tumors and controls, but were elevated in the unusual 8-Ung À/À tumor (Figure 3c ), in agreement with its high constitutive level of Aid expression (Figure 1) . Moreover, mutations in typical Ung other DNA glycosylases, different from Ung, have been found to be associated with increased tumor frequencies in tissues such as colon, ovary and lung (for a review, see Barnes and Lindahl, 2004) . As noted previously by Gearhart (2003) , the association of an Ung deficiency in mice with B-cell lymphomas, but not other tumors, suggests that stochastic events associated with the unique molecular processing of antibody genes accounts for the appearance of malignant B-cell transformation in Ung-deficient mice. In Ung-negative cells, dU Á dG base pairs generated in antibody V genes by the Aid deaminase require the Msh2-dependent mismatch repair system for further processing (Rada et al., 2004) ; the apparently lower efficiency and longer repair patches of this back-up system by comparison with Ung-dependent base excision repair might be associated with an increased risk of error-prone alterations.
